BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 30910845)

  • 1. Association of IL-1β gene polymorphisms rs1143627, rs1799916, and rs16944 with altered risk of triple-negative breast cancer.
    Sghaier I; Sheridan JM; Daldoul A; El-Ghali RM; Al-Awadi AM; Habel AF; Aimagambetova G; Almawi WY
    Cytokine; 2024 Aug; 180():156659. PubMed ID: 38781872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and Validation of Three-Gene Signature in Lung Squamous Cell Carcinoma by Integrated Transcriptome and Methylation Analysis.
    Li G; Wu L; Yu J; Zhai S; Deng H; Wang Q
    J Oncol; 2022; 2022():9688040. PubMed ID: 36193204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metaplastic Carcinoma of the Breast Is More Aggressive Than Triple-negative Breast Cancer: A Study From a Single Institution and Review of Literature.
    El Zein D; Hughes M; Kumar S; Peng X; Oyasiji T; Jabbour H; Khoury T
    Clin Breast Cancer; 2017 Aug; 17(5):382-391. PubMed ID: 28529029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms in
    Hu A; Li J; Ruan S; Fan Y; Liao Y
    Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30910845
    [No Abstract]   [Full Text] [Related]  

  • 5. A CLDN1-negative phenotype predicts poor prognosis in triple-negative breast cancer.
    Ma F; Ding X; Fan Y; Ying J; Zheng S; Lu N; Xu B
    PLoS One; 2014; 9(11):e112765. PubMed ID: 25393310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms in
    Liao Y; Liao Y; Li J; Li J; Fan Y; Xu B
    Cancer Manag Res; 2018; 10():3801-3808. PubMed ID: 30288111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic polymorphisms of autophagy-related gene 5 (ATG5) rs473543 predict different disease-free survivals of triple-negative breast cancer patients receiving anthracycline- and/or taxane-based adjuvant chemotherapy.
    Li M; Ma F; Wang J; Li Q; Zhang P; Yuan P; Luo Y; Cai R; Fan Y; Chen S; Li Q; Xu B
    Chin J Cancer; 2018 Jan; 37(1):4. PubMed ID: 29382381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms in PARP1 predict disease-free survival of triple-negative breast cancer patients treated with anthracycline/taxane based adjuvant chemotherapy.
    Liao Y; Liao Y; Li J; Xiong J; Fan Y
    Sci Rep; 2020 Apr; 10(1):7349. PubMed ID: 32355298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms in the CLDN1 and CLDN7 genes are related to differentiation and tumor stage in colon carcinoma.
    Hahn-Strömberg V; Askari S; Befekadu R; Matthiessen P; Karlsson S; Nilsson TK
    APMIS; 2014 Jul; 122(7):636-42. PubMed ID: 24479816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic Alterations Associated with Recurrence and TNBC Subtype in High-Risk Early Breast Cancers.
    Wilson TR; Udyavar AR; Chang CW; Spoerke JM; Aimi J; Savage HM; Daemen A; O'Shaughnessy JA; Bourgon R; Lackner MR
    Mol Cancer Res; 2019 Jan; 17(1):97-108. PubMed ID: 30171174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CLDN6 promotes chemoresistance through GSTP1 in human breast cancer.
    Yang M; Li Y; Shen X; Ruan Y; Lu Y; Jin X; Song P; Guo Y; Zhang X; Qu H; Shao Y; Quan C
    J Exp Clin Cancer Res; 2017 Nov; 36(1):157. PubMed ID: 29116019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How many diseases is triple negative breast cancer: the protagonism of the immune microenvironment.
    Saraiva DP; Guadalupe Cabral M; Jacinto A; Braga S
    ESMO Open; 2017; 2(4):e000208. PubMed ID: 29018573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment and Application of a Universal Coronavirus Screening Method Using MALDI-TOF Mass Spectrometry.
    Xiu L; Zhang C; Wu Z; Peng J
    Front Microbiol; 2017; 8():1510. PubMed ID: 28848521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Biology In Young Women With Breast Cancer: From Tumor Gene Expression To DNA Mutations.
    Gómez-Flores-Ramos L; Castro-Sánchez A; Peña-Curiel O; Mohar-Betancourt A
    Rev Invest Clin; 2017; 69(4):181-192. PubMed ID: 28776603
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.